*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
D090 - Carcinoma in situ of bladder - as a primary diagnosis code | D090 - Carcinoma in situ of bladder - as a primary or secondary diagnosis code | |
---|---|---|
OUTCOMES | ||
Avg. LOS | 5.98 | |
Readmission Rate (%) | 24.78 | |
Unplanned Readmission Rate (%) | 17.63 | |
Mortality Rate (%) | ||
SNF Discharge Rate (%) | ||
Home Discharge Rate (%) | ||
PAYMENTS AND CHARGES | ||
Total Medicare Payments | ||
Payment Per Day | ||
Payment Per Hospitalization | ||
Total Medicare Charges | ||
Avg. Charges | ||
MARKET SIZING & INCIDENCE RATES | ||
Total National Projected Hospitalizations - Annualized (Present on Admission - All) | ||
Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - All) | ||
Total National Projected Hospitalizations - Annualized (Present on Admission - Yes) | ||
Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Yes) | ||
Total National Projected Hospitalizations - Annualized (Present on Admission - Not Y) | ||
Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Not Y) | ||
Total Medicare Hospitalizations after Exclusion |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
DRG 654: MAJOR BLADDER PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | DRG 655: MAJOR BLADDER PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 669: TRANSURETHRAL PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | DRG 670: TRANSURETHRAL PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 653: MAJOR BLADDER PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
---|---|---|---|---|---|
Total Hospitalizations at DRG | 13,513 | ||||
Total Hospitalizations with ICD D090 - Carcinoma in situ of bladder | 246 | ||||
DRG Share of Total Hospitalizations | 0.04 | ||||
% of Total ICD D090 - Carcinoma in situ of bladder in DRG | 28.41 | ||||
Avg LOS at DRG | 7.02 | ||||
Avg LOS with ICD D090 - Carcinoma in situ of bladder | 7.53 | ||||
Readmission Rate at DRG | 26.89 | ||||
Readmission Rate with ICD D090 - Carcinoma in situ of bladder | 30.71 | ||||
Unplanned Readmission Rate at DRG | 18.36 | ||||
Unplanned Readmission Rate with ICD D090 - Carcinoma in situ of bladder | 22.41 | ||||
Total Medicare payments at DRG | $270,065,366 | ||||
Total Medicare payments with ICD D090 - Carcinoma in situ of bladder | $4,974,566 | ||||
Total Medicare payment per Day at DRG | $2,848 | ||||
Total Medicare payment per Day with ICD D090 - Carcinoma in situ of bladder | $2,685 | ||||
Total Medicare payment per Hospitalization at DRG | $19,986 | ||||
Total Medicare payment per Hospitalization with ICD D090 - Carcinoma in situ of bladder | $20,222 | ||||
Total Medicare Charges at DRG | $1,412,381,149 | ||||
Total Medicare Charges with ICD D090 - Carcinoma in situ of bladder | $27,760,201 | ||||
Avg Charges at DRG | $104,520 | ||||
Avg Charges with ICD D090 - Carcinoma in situ of bladder | $112,846 | ||||
Mortality Rate at DRG | 0.21 | ||||
Mortality Rate with ICD D090 - Carcinoma in situ of bladder | NA | ||||
SNF Discharge Rate at DRG | 15.04 | ||||
SNF Discharge Rate with ICD D090 - Carcinoma in situ of bladder | 10.98 | ||||
Home Discharge Rate at DRG | 33.15 | ||||
Home Discharge Rate with ICD D090 - Carcinoma in situ of bladder | 27.24 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
DRG 668: TRANSURETHRAL PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 687: KIDNEY AND URINARY TRACT NEOPLASMS WITH COMPLICATION OR COMORBIDITY (CC) | DRG 666: PROSTATECTOMY WITH COMPLICATION OR COMORBIDITY (CC) | DRG 657: KIDNEY AND URETER PROCEDURES FOR NEOPLASM WITH COMPLICATION OR COMORBIDITY (CC) | DRG 667: PROSTATECTOMY WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
---|---|---|---|---|---|
Total Hospitalizations at DRG | 10,891 | ||||
Total Hospitalizations with ICD D090 - Carcinoma in situ of bladder | 48 | ||||
DRG Share of Total Hospitalizations | 0.03 | ||||
% of Total ICD D090 - Carcinoma in situ of bladder in DRG | 5.54 | ||||
Avg LOS at DRG | 8.48 | ||||
Avg LOS with ICD D090 - Carcinoma in situ of bladder | 8.38 | ||||
Readmission Rate at DRG | 28.33 | ||||
Readmission Rate with ICD D090 - Carcinoma in situ of bladder | 31.11 | ||||
Unplanned Readmission Rate at DRG | 20.09 | ||||
Unplanned Readmission Rate with ICD D090 - Carcinoma in situ of bladder | NA | ||||
Total Medicare payments at DRG | $184,732,838 | ||||
Total Medicare payments with ICD D090 - Carcinoma in situ of bladder | $801,221 | ||||
Total Medicare payment per Day at DRG | $2,001 | ||||
Total Medicare payment per Day with ICD D090 - Carcinoma in situ of bladder | $1,993 | ||||
Total Medicare payment per Hospitalization at DRG | $16,962 | ||||
Total Medicare payment per Hospitalization with ICD D090 - Carcinoma in situ of bladder | $16,692 | ||||
Total Medicare Charges at DRG | $955,216,524 | ||||
Total Medicare Charges with ICD D090 - Carcinoma in situ of bladder | $4,387,527 | ||||
Avg Charges at DRG | $87,707 | ||||
Avg Charges with ICD D090 - Carcinoma in situ of bladder | $91,407 | ||||
Mortality Rate at DRG | 3.54 | ||||
Mortality Rate with ICD D090 - Carcinoma in situ of bladder | NA | ||||
SNF Discharge Rate at DRG | 27.45 | ||||
SNF Discharge Rate with ICD D090 - Carcinoma in situ of bladder | NA | ||||
Home Discharge Rate at DRG | 35.91 | ||||
Home Discharge Rate with ICD D090 - Carcinoma in situ of bladder | 39.58 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
DRG 658: KIDNEY AND URETER PROCEDURES FOR NEOPLASM WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
---|---|
Total Hospitalizations at DRG | 20,028 |
Total Hospitalizations with ICD D090 - Carcinoma in situ of bladder | 13 |
DRG Share of Total Hospitalizations | 0.06 |
% of Total ICD D090 - Carcinoma in situ of bladder in DRG | 1.5 |
Avg LOS at DRG | 2.59 |
Avg LOS with ICD D090 - Carcinoma in situ of bladder | 2.15 |
Readmission Rate at DRG | 6.97 |
Readmission Rate with ICD D090 - Carcinoma in situ of bladder | NA |
Unplanned Readmission Rate at DRG | 5.04 |
Unplanned Readmission Rate with ICD D090 - Carcinoma in situ of bladder | NA |
Total Medicare payments at DRG | $183,727,361 |
Total Medicare payments with ICD D090 - Carcinoma in situ of bladder | $135,312 |
Total Medicare payment per Day at DRG | $3,540 |
Total Medicare payment per Day with ICD D090 - Carcinoma in situ of bladder | $4,833 |
Total Medicare payment per Hospitalization at DRG | $9,174 |
Total Medicare payment per Hospitalization with ICD D090 - Carcinoma in situ of bladder | $10,409 |
Total Medicare Charges at DRG | $1,163,601,839 |
Total Medicare Charges with ICD D090 - Carcinoma in situ of bladder | $732,965 |
Avg Charges at DRG | $58,099 |
Avg Charges with ICD D090 - Carcinoma in situ of bladder | $56,382 |
Mortality Rate at DRG | NA |
Mortality Rate with ICD D090 - Carcinoma in situ of bladder | NA |
SNF Discharge Rate at DRG | 2.51 |
SNF Discharge Rate with ICD D090 - Carcinoma in situ of bladder | NA |
Home Discharge Rate at DRG | 88.81 |
Home Discharge Rate with ICD D090 - Carcinoma in situ of bladder | 100.0 |
Hospital Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
---|---|---|---|---|---|
MEMORIAL SLOAN KETTERING CANCER CENTER | 1275 YORK AVE | NEW YORK | NY | 10065 | 42 |
MAYO CLINIC HOSPITAL - SAINT MARYS CAMPUS | 1216 2ND ST SW | ROCHESTER | MN | 55902 | 30 |
MOFFITT CANCER CENTER | 12902 MAGNOLIA DR | TAMPA | FL | 33612 | 23 |
Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
---|---|---|---|---|---|
Dr. GUIDO DALBAGNI | 1275 YORK AVE | NEW YORK | NY | 10021 | 15 |
Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
---|---|---|---|---|---|
Dr. GUIDO DALBAGNI | 1275 YORK AVE | NEW YORK | NY | 10021 | 15 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
DRG 654: MAJOR BLADDER PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | DRG 669: TRANSURETHRAL PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | DRG 655: MAJOR BLADDER PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 670: TRANSURETHRAL PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 653: MAJOR BLADDER PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
---|---|---|---|---|---|
Total Hospitalizations at DRG | 13,513 | ||||
Total Hospitalizations with ICD D090 - Carcinoma in situ of bladder | 378 | ||||
DRG Share of Total Hospitalizations | 0.04 | ||||
% of Total ICD D090 - Carcinoma in situ of bladder in DRG | 15.49 | ||||
Avg LOS at DRG | 7.02 | ||||
Avg LOS with ICD D090 - Carcinoma in situ of bladder | 7.19 | ||||
Readmission Rate at DRG | 26.89 | ||||
Readmission Rate with ICD D090 - Carcinoma in situ of bladder | 28.03 | ||||
Unplanned Readmission Rate at DRG | 18.36 | ||||
Unplanned Readmission Rate with ICD D090 - Carcinoma in situ of bladder | 20.49 | ||||
Total Medicare payments at DRG | $270,065,366 | ||||
Total Medicare payments with ICD D090 - Carcinoma in situ of bladder | $7,641,747 | ||||
Total Medicare payment per Day at DRG | $2,848 | ||||
Total Medicare payment per Day with ICD D090 - Carcinoma in situ of bladder | $2,813 | ||||
Total Medicare payment per Hospitalization at DRG | $19,986 | ||||
Total Medicare payment per Hospitalization with ICD D090 - Carcinoma in situ of bladder | $20,216 | ||||
Total Medicare Charges at DRG | $1,412,381,149 | ||||
Total Medicare Charges with ICD D090 - Carcinoma in situ of bladder | $40,870,552 | ||||
Avg Charges at DRG | $104,520 | ||||
Avg Charges with ICD D090 - Carcinoma in situ of bladder | $108,123 | ||||
Mortality Rate at DRG | 0.21 | ||||
Mortality Rate with ICD D090 - Carcinoma in situ of bladder | NA | ||||
SNF Discharge Rate at DRG | 15.04 | ||||
SNF Discharge Rate with ICD D090 - Carcinoma in situ of bladder | 9.79 | ||||
Home Discharge Rate at DRG | 33.15 | ||||
Home Discharge Rate with ICD D090 - Carcinoma in situ of bladder | 24.87 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
DRG 668: TRANSURETHRAL PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 657: KIDNEY AND URETER PROCEDURES FOR NEOPLASM WITH COMPLICATION OR COMORBIDITY (CC) | DRG 690: KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 988: NON-EXTENSIVE O.R. PROC UNRELATED TO PRINCIPAL DIAGNOSIS WITH COMPLICATION OR COMORBIDITY (CC) | |
---|---|---|---|---|---|
Total Hospitalizations at DRG | 10,891 | ||||
Total Hospitalizations with ICD D090 - Carcinoma in situ of bladder | 76 | ||||
DRG Share of Total Hospitalizations | 0.03 | ||||
% of Total ICD D090 - Carcinoma in situ of bladder in DRG | 3.11 | ||||
Avg LOS at DRG | 8.48 | ||||
Avg LOS with ICD D090 - Carcinoma in situ of bladder | 8.58 | ||||
Readmission Rate at DRG | 28.33 | ||||
Readmission Rate with ICD D090 - Carcinoma in situ of bladder | 28.57 | ||||
Unplanned Readmission Rate at DRG | 20.09 | ||||
Unplanned Readmission Rate with ICD D090 - Carcinoma in situ of bladder | 21.43 | ||||
Total Medicare payments at DRG | $184,732,838 | ||||
Total Medicare payments with ICD D090 - Carcinoma in situ of bladder | $1,240,384 | ||||
Total Medicare payment per Day at DRG | $2,001 | ||||
Total Medicare payment per Day with ICD D090 - Carcinoma in situ of bladder | $1,902 | ||||
Total Medicare payment per Hospitalization at DRG | $16,962 | ||||
Total Medicare payment per Hospitalization with ICD D090 - Carcinoma in situ of bladder | $16,321 | ||||
Total Medicare Charges at DRG | $955,216,524 | ||||
Total Medicare Charges with ICD D090 - Carcinoma in situ of bladder | $6,507,219 | ||||
Avg Charges at DRG | $87,707 | ||||
Avg Charges with ICD D090 - Carcinoma in situ of bladder | $85,621 | ||||
Mortality Rate at DRG | 3.54 | ||||
Mortality Rate with ICD D090 - Carcinoma in situ of bladder | NA | ||||
SNF Discharge Rate at DRG | 27.45 | ||||
SNF Discharge Rate with ICD D090 - Carcinoma in situ of bladder | 25.0 | ||||
Home Discharge Rate at DRG | 35.91 | ||||
Home Discharge Rate with ICD D090 - Carcinoma in situ of bladder | 38.16 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
DRG 872: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 699: OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH COMPLICATION OR COMORBIDITY (CC) | DRG 687: KIDNEY AND URINARY TRACT NEOPLASMS WITH COMPLICATION OR COMORBIDITY (CC) | DRG 696: KIDNEY AND URINARY TRACT SIGNS AND SYMPTOMS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 666: PROSTATECTOMY WITH COMPLICATION OR COMORBIDITY (CC) | |
---|---|---|---|---|---|
Total Hospitalizations at DRG | 499,133 | ||||
Total Hospitalizations with ICD D090 - Carcinoma in situ of bladder | 40 | ||||
DRG Share of Total Hospitalizations | 1.52 | ||||
% of Total ICD D090 - Carcinoma in situ of bladder in DRG | 1.64 | ||||
Avg LOS at DRG | 4.34 | ||||
Avg LOS with ICD D090 - Carcinoma in situ of bladder | 3.88 | ||||
Readmission Rate at DRG | 17.57 | ||||
Readmission Rate with ICD D090 - Carcinoma in situ of bladder | NA | ||||
Unplanned Readmission Rate at DRG | 12.56 | ||||
Unplanned Readmission Rate with ICD D090 - Carcinoma in situ of bladder | NA | ||||
Total Medicare payments at DRG | $3,254,711,780 | ||||
Total Medicare payments with ICD D090 - Carcinoma in situ of bladder | $300,763 | ||||
Total Medicare payment per Day at DRG | $1,504 | ||||
Total Medicare payment per Day with ICD D090 - Carcinoma in situ of bladder | $1,940 | ||||
Total Medicare payment per Hospitalization at DRG | $6,521 | ||||
Total Medicare payment per Hospitalization with ICD D090 - Carcinoma in situ of bladder | $7,519 | ||||
Total Medicare Charges at DRG | $16,863,396,143 | ||||
Total Medicare Charges with ICD D090 - Carcinoma in situ of bladder | $1,166,639 | ||||
Avg Charges at DRG | $33,785 | ||||
Avg Charges with ICD D090 - Carcinoma in situ of bladder | $29,166 | ||||
Mortality Rate at DRG | 1.33 | ||||
Mortality Rate with ICD D090 - Carcinoma in situ of bladder | NA | ||||
SNF Discharge Rate at DRG | 19.89 | ||||
SNF Discharge Rate with ICD D090 - Carcinoma in situ of bladder | NA | ||||
Home Discharge Rate at DRG | 49.27 | ||||
Home Discharge Rate with ICD D090 - Carcinoma in situ of bladder | 62.5 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
DRG 853: INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 698: OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 658: KIDNEY AND URETER PROCEDURES FOR NEOPLASM WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 682: RENAL FAILURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
---|---|---|---|---|---|
Total Hospitalizations at DRG | 269,064 | ||||
Total Hospitalizations with ICD D090 - Carcinoma in situ of bladder | 27 | ||||
DRG Share of Total Hospitalizations | 0.82 | ||||
% of Total ICD D090 - Carcinoma in situ of bladder in DRG | 1.11 | ||||
Avg LOS at DRG | 13.18 | ||||
Avg LOS with ICD D090 - Carcinoma in situ of bladder | 8.89 | ||||
Readmission Rate at DRG | 37.51 | ||||
Readmission Rate with ICD D090 - Carcinoma in situ of bladder | 47.83 | ||||
Unplanned Readmission Rate at DRG | 18.15 | ||||
Unplanned Readmission Rate with ICD D090 - Carcinoma in situ of bladder | NA | ||||
Total Medicare payments at DRG | $9,344,186,034 | ||||
Total Medicare payments with ICD D090 - Carcinoma in situ of bladder | $709,735 | ||||
Total Medicare payment per Day at DRG | $2,635 | ||||
Total Medicare payment per Day with ICD D090 - Carcinoma in situ of bladder | $2,957 | ||||
Total Medicare payment per Hospitalization at DRG | $34,728 | ||||
Total Medicare payment per Hospitalization with ICD D090 - Carcinoma in situ of bladder | $26,286 | ||||
Total Medicare Charges at DRG | $44,371,117,432 | ||||
Total Medicare Charges with ICD D090 - Carcinoma in situ of bladder | $3,134,989 | ||||
Avg Charges at DRG | $164,909 | ||||
Avg Charges with ICD D090 - Carcinoma in situ of bladder | $116,111 | ||||
Mortality Rate at DRG | 14.37 | ||||
Mortality Rate with ICD D090 - Carcinoma in situ of bladder | NA | ||||
SNF Discharge Rate at DRG | 31.8 | ||||
SNF Discharge Rate with ICD D090 - Carcinoma in situ of bladder | NA | ||||
Home Discharge Rate at DRG | 14.61 | ||||
Home Discharge Rate with ICD D090 - Carcinoma in situ of bladder | NA |
Hospital Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
---|---|---|---|---|---|
MEMORIAL SLOAN KETTERING CANCER CENTER | 1275 YORK AVE | NEW YORK | NY | 10065 | 154 |
MAYO CLINIC HOSPITAL - SAINT MARYS CAMPUS | 1216 2ND ST SW | ROCHESTER | MN | 55902 | 53 |
FOX CHASE CANCER CENTER | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111 | 44 |
Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
---|---|---|---|---|---|
Dr. GUIDO DALBAGNI | 1275 YORK AVE | NEW YORK | NY | 10021 | 37 |
Dr. BERNARD H BOCHNER | 1275 YORK AVE | NEW YORK | NY | 10021 | 25 |
Dr. HARRY W HERR | 1275 YORK AVE | NEW YORK | NY | 10021 | 24 |
Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
---|---|---|---|---|---|
Dr. GUIDO DALBAGNI | 1275 YORK AVE | NEW YORK | NY | 10021 | 41 |
Dr. BERNARD H BOCHNER | 1275 YORK AVE | NEW YORK | NY | 10021 | 31 |
Dr. HARRY W HERR | 1275 YORK AVE | NEW YORK | NY | 10021 | 27 |